Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: CRESTONE, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2020-07-01 to 2025-07-09
Current total value of award: $15976042
Description: TO ADVANCE A PROMISING, SMALL-MOLECULE COMPOUND CRS0540 TO IND FILING AND THROUGH PHASE I CLINICAL STUDIES.